Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification
Praveen Anand,Enas Elsafa,Rosario Privitera,Kalnisha Naidoo,Yiangos Yiangou,Philippe Donatien,Hani Gabra,Harpreet Wasan,Laura Kenny,Amin Rahemtulla,Peter Misra
DOI: https://doi.org/10.2147/JPR.S213912
IF: 2.8319
2019-10-08
Journal of Pain Research
Abstract:Praveen Anand, 1 Enas Elsafa, 1 Rosario Privitera, 1 Kalnisha Naidoo, 1 Yiangos Yiangou, 1 Philippe Donatien, 1 Hani Gabra, 2 Harpreet Wasan, 2 Laura Kenny, 2 Amin Rahemtulla, 3 Peter Misra 1 1 Department of Neurology; 2 Medical Oncology; 3 Hematology, Imperial College London, Hammersmith Hospital, London W12 0NN, UK Purpose: Chemotherapy-induced peripheral neuropathy (CIPN) with associated chronic pain is a common and disabling condition. Current treatments for neuropathic pain in CIPN are largely ineffective, with unfavorable side-effects. The capsaicin 8% patch (capsaicin 179 mg patch) is approved for the treatment of neuropathic pain: a single topical cutaneous application can produce effective pain relief for up to 12 weeks. We assessed the therapeutic potential of capsaicin 8% patch in patients with painful CIPN, and its mechanism of action. Patients and methods: 16 patients with chronic painful CIPN (mean duration 2.5 years), in remission for cancer and not receiving chemotherapy, were treated with 30 min application of capsaicin 8% patch to the feet. Symptoms were monitored using the 11-point numerical pain rating scale (NPRS), and questionnaires. Investigations were performed at baseline and three months after patch application, including skin biopsies with a range of markers, and quantitative sensory testing (QST). Results: Patients reported significant reduction in spontaneous pain (mean NPRS: −1.27; 95% CI 0.2409 to 2.301; p =0.02), touch-evoked pain (−1.823; p =0.03) and cold-evoked pain (−1.456; p =0.03). Short-Form McGill questionnaire showed a reduction in neuropathic ( p =0.0007), continuous ( p =0.01) and overall pain ( p =0.004); Patient Global Impression of Change showed improvement ( p =0.001). Baseline skin biopsies showed loss of intra-epidermal nerve fibers (IENF), and also of sub-epidermal nerve fibers quantified by image analysis. Post-patch application skin biopsies showed a significant increase towards normalization of intra-epidermal and sub-epidermal nerve fibers (for IENF: structural marker PGP9.5, p =0.009; heat receptor TRPV1, p =0.027; regenerating nerve marker GAP43, p =0.04). Epidermal levels of Nerve Growth Factor (NGF), Neurotrophin-3 (NT-3), and Langerhans cells were also normalized. QST remained unchanged and there were no systemic side-effects, as in previous studies. Conclusion: Capsaicin 8% patch provides significant pain relief in CIPN, and may lead to regeneration and restoration of sensory nerve fibers ie, disease modification. Keywords: capsaicin, neuropathic pain, chemotherapy, skin biopsy
clinical neurology